Epsilon Health Investors, LLC is a venture capital firm specializing in digital healthcare investments. Founded by healthcare veterans Steven Epstein and Gregory Epstein of Epstein Becker & Green, P. C., Epsilon brings decades of experience in healthcare investing, regulatory support, and board leadership to the table.

They manage capital on behalf of a group of strategic limited partners and commercial investors. Epsilon's investment focus is on digital health companies that address significant pain points and inefficiencies in the healthcare system. They primarily invest in seed+ to Series B stage companies in the digital health sector, including healthcare IT and technology-enabled services.

Their current portfolio includes a range of innovative companies such as Axuall, Banjo Health, Cylera, Health Gorilla, Luma Health, Marigold, RemedyLogic, Suki, Vesta Healthcare, and wayForward, each addressing critical needs in the healthcare industry through cutting-edge solutions. Epsilon differentiates itself by providing valuable strategic support and guidance to their portfolio companies. With a vast healthcare network and unparalleled industry insight, Epsilon helps their investments achieve scale and succeed in the digital transformation of healthcare.

As a trusted venture capital firm, Epsilon manages capital on behalf of an impressive group of limited partners, including health systems, health plans, healthcare organizations, family offices, and renowned healthcare executives and entrepreneurs. They offer unique industry insights and valuable introductions through their extensive healthcare network. With a team boasting extensive experience as investors, directors, and advisors in the healthcare sector, Epsilon has previously invested in notable companies such as Acumen Healthcare, Team Health, Syft, Cognitive Clinical Trials, Inception Fertility, Catamaran, MedExpress, BrightSpring, Restorix Health, and Solis Women's Health.

Epsilon Health Investors, LLC is committed to driving the digital transformation of healthcare by supporting and investing in innovative digital health companies that significantly improve the efficiency and effectiveness of the healthcare system